Editorial: Transfer-factor therapy of immunodeficiencies.
D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology; D001402:B-Lymphocytes / Q000276:immunology; D001796:Blood Protein Disorders / Q000209:etiology; D002179:Candidiasis, Cutaneous / Q000628:therapy; D002648:Child; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive / Q000009:adverse effects; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D007223:Infant; D007938:Leukemia / Q000209:etiology; D008223:Lymphoma / Q000209:etiology; D014923:Wiskott-Aldrich Syndrome / Q000628:therapy; D005719:gamma-Globulins
D005719:gamma-Globulins